MediciNova

MNOV

Market cap $68.7M

1.42 USD

--0.09

5.96%

At close Updated Nov 7, 4:00 PM EST

Pre-market

After hours

1.44

+0.02

1.41%

1 day

-5.96%

5 days

4.41%

1 month

10.08%

3 months

4.41%

6 months

-4.05%

Year to date

-33.33%

1 year

-8.97%

5 years

-76.09%

10 years

-54.78%

About: MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.

Employees: 6

Healthcare Biotechnology